Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.6300
-0.0400 (-5.97%)
At close: Feb 4, 2026

Cleo Diagnostics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Feb '26 Jun '25 Jun '24 Jun '23
825044-
Market Cap Growth
77.51%14.71%--
Enterprise Value
764334-
Last Close Price
0.600.390.34-
PS Ratio
97.1659.30207.25-
PB Ratio
14.078.594.65-
P/TBV Ratio
15.009.154.86-
EV/Sales Ratio
89.5250.65159.30-
Debt / Equity Ratio
----1.70
Asset Turnover
0.100.100.04-
Quick Ratio
5.935.9319.400.13
Current Ratio
5.945.9419.410.29
Return on Equity (ROE)
-52.53%-52.53%-88.99%-
Return on Assets (ROA)
-30.35%-30.35%-41.55%-
Return on Capital Employed (ROCE)
-70.00%-70.00%-38.80%180.20%
Earnings Yield
-4.87%-7.98%-8.60%-
FCF Yield
-3.55%-5.81%-4.65%-
Buyback Yield / Dilution
-9.53%-9.53%-346.76%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.